Evidence map›Paper›PMID 30349866›Full record

ArticleAnnals of clinical and translational neurology2018

G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis.

Alina Tomescu-Baciu, Frode Vartdal, Trygve Holmøy, Christian A Vedeler, Andreas Lossius

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis.Annals of clinical and translational neurology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Alina Tomescu-BaciuDepartment of Immunology and Transfusion Medicine Faculty of Medicine University of Oslo Oslo University Hospital Rikshospitalet Oslo Norway.
Frode VartdalDepartment of Immunology and Transfusion Medicine Faculty of Medicine University of Oslo Oslo University Hospital Rikshospitalet Oslo Norway.
Trygve HolmøyInstitute of Clinical Medicine Faculty of Medicine University of Oslo Oslo Norway.ORCID 0000-0002-2529-5664
Christian A VedelerDepartment of Clinical Medicine University of Bergen Bergen Norway.
Andreas LossiusDepartment of Immunology and Transfusion Medicine Faculty of Medicine University of Oslo Oslo University Hospital Rikshospitalet Oslo Norway.ORCID 0000-0002-9640-1954
Oslo University Hospital · NOHaukeland University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously shown that plasmablasts of the G1m1 allotype of IgG1 are selectively enriched in the cerebrospinal fluid of G1m1/G1m3 heterozygous patients with multiple sclerosis, whereas both allotypes are equally used in neuroborreliosis. Here, we demonstrate a strong preference for the G1m1 allotype in the intrathecal humoral immune responses against measles, rubella, and varicella zoster virus in G1m1/G1m3 heterozygous multiple sclerosis patients. Conversely, intrathecally synthesized varicella zoster virus-specific IgG1 in varicella zoster virus meningoencephalitis comprised both allotypes. This implies that G1m1 B cells are selected to the central nervous system of multiple sclerosis patients regardless of specificity and suggests that an antigen-independent mechanism could drive the intrathecal humoral immune response.

Identifiers

PMID30349866
PMCPMC6186941
OpenAlexW2891492198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.